Drug Development
搜索文档
Seaport Therapeutics (NasdaqGS:SPTX) Earnings Call Presentation
2026-09-09 19:00
Corporate Presentation September 2026 CONFIDENTIAL Turning the Tide on Mental Health Disclaimer This presentation includes forward-looking statements, including, but not limited to, express or implied statements about Seaport's beliefs and expectations regarding: the potential of the Glyph platform to enhance oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects associated with clinically validated neuropsychiatric therapeutics; the continued development and adv ...